Turoctocog alfa: an evidence-based review of its potential in the treatment of hemophilia A

about

Interim results from a large multinational extension trial (guardian(™) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A.

P2860

Q45855075-C36F7C35-28B2-4317-BF51-EE8CCEFF1319

P2860

Turoctocog alfa: an evidence-based review of its potential in the treatment of hemophilia A

Item

http://www.wikidata.org/entity/Q38408739

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Turoctocog alfa: an evidence-b ...... the treatment of hemophilia A

@en

type

Item

label

Turoctocog alfa: an evidence-b ...... the treatment of hemophilia A

@en

prefLabel

Turoctocog alfa: an evidence-b ...... the treatment of hemophilia A

@en

P1476

Turoctocog alfa: an evidence-b ...... the treatment of hemophilia A

@en

P2093

Hideyuki Takedani

http://www.w3.org/2001/XMLSchema#string

Jun Hirose

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

The protein structure and effect of factor VIII.

Defining 'full-length' recombinant factor VIII: a comparative structural analysis.

Purification and characterization of a new recombinant factor VIII (N8).

The hemophilias--from royal genes to gene therapy.

Safety and efficacy of turoctocog alfa (NovoEight®) during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials.

Treatment of hemophilia: a review of current advances and ongoing issues

A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management

Modern treatment of haemophilia

Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia A

Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII (N8) in haemophilia A dogs.

P304

1767-1772

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/DDDT.S57967

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2015-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25848213

http://www.w3.org/2001/XMLSchema#string

P921

P932

4378277

http://www.w3.org/2001/XMLSchema#string

Turoctocog alfa: an evidence-based review of its potential in the treatment of hemophilia A

about

P2860

P2860

Turoctocog alfa: an evidence-based review of its potential in the treatment of hemophilia A

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P478

P5008

P577

P698

P921

P932